Back to News
Market Impact: 0.2
Consensus Price Target for Ryman Healthcare Limited - Depositary Receipt Increases 13.54% to $9.13
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for Ryman Healthcare Limited’s depositary receipt was revised up 13.54% to $9.13 per share from $8.04 on October 22, 2026. The report provides an analyst estimate revision, not evidence of a change in company performance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares